Endoscopic Closure of Tracheoesophageal Fistulas With Occluder Device
Phase 4
Terminated
- Conditions
- Acquired Tracheo-esophageal Fistula
- Interventions
- Device: Fistula closure with Gore Helex Septal OccluderDevice: Gore Helex Septal Occluder
- Registration Number
- NCT01153061
- Lead Sponsor
- University of Sao Paulo
- Brief Summary
Endoscopic closure of tracheoesophageal fistulas with a device used for closure of cardiac septal defects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
- Patients over 14 years old
- Benign tracheoesophageal fistulas identified through bronchoscopy;
Exclusion Criteria
- Malign neoplasia
- Current mechanical ventilation
- Immunosuppressed
- Current local inflammatory process at fistulas borders
- Other clinical risk factors
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Fistula closure with occluder Gore Helex Septal Occluder Patients with benign tracheoesophageal fistulas will be submitted to the correction with the occluder. Fistula closure with occluder Fistula closure with Gore Helex Septal Occluder Patients with benign tracheoesophageal fistulas will be submitted to the correction with the occluder.
- Primary Outcome Measures
Name Time Method Closure of tracheoesophageal fistulas with the Gore Helex Septal Occluder 6 months The closure will be confirmed by endoscopic or bronchoscopic observation of the fistula at regular intervals: one week, two weeks, and four weeks after implant of the occluder.
A thorax CT scan will ascertain correct positioning and stability of the occluder.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Heart Institute (InCor)-Clinics Hospital Sao Paulo University Medical School
🇧🇷Sao Paulo, Brazil